Cargando…
Effect of hepatic iron concentration and viral factors in chronic hepatitis C-infected patients with thalassemia major, treated with interferon and ribavirin
BACKGROUND: Beta thalassemia major patients are vulnerable to transfusion-transmitted infection, especially hepatitis C virus (HCV), and iron overload. These comorbidities lead to cirrhosis and hepatocellular carcinoma in these patients. In order to prevent these complications, treatment of HCV infe...
Autores principales: | Jafroodi, Maryam, Asadi, Ramin, Heydarzadeh, Abtin, Besharati, Sepiedeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150176/ https://www.ncbi.nlm.nih.gov/pubmed/21845061 http://dx.doi.org/10.2147/IJGM.S19643 |
Ejemplares similares
-
Trend in Prevalence of Hepatitis C Virus Infection among β-thalassemia Major Patients: 10 Years of Experience in Iran
por: Jafroodi, Maryam, et al.
Publicado: (2015) -
Hepatitis C and hepatitis B seroprevalence and associated risk factors in hemodialysis patients in Guilan province, north of Iran: HCV and HBV seroprevalence in hemodialysis patients
por: Joukar, Farahnaz, et al.
Publicado: (2011) -
Liver Enzymes in Children with beta-Thalassemia Major: Correlation with Iron Overload and Viral Hepatitis
por: Salama, Khaled M., et al.
Publicado: (2015) -
Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin
por: Abbas, Zaigham, et al.
Publicado: (2013) -
Low Dose Ribavirin for Treatment of Hepatitis C Virus Infected Thalassemia Major Patients; New Indications for Combination Therapy
por: Tabatabaei, Seyed Vahid, et al.
Publicado: (2012)